IL6 and neoplasm: IL-6-/- mice treated with gDE7 and D-1MT had a 73% survival rate and 52% remained tumor-free till the end of the observation period (D60), whereas animals treated with gDE7 and DL-1MT had a 52% survival rate and 47% were tumor-free.